![]() ![]() LeMaitre shares have added about 18.8% since the beginning of the year versus the S&P 500's gain of 8.6%. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. The company has topped consensus revenue estimates two times over the last four quarters. This compares to year-ago revenues of $39.56 million. LeMaitre, which belongs to the Zacks Medical - Products industry, posted revenues of $47.08 million for the quarter ended March 2023, surpassing the Zacks Consensus Estimate by 7.63%. Over the last four quarters, the company has surpassed consensus EPS estimates just once. A quarter ago, it was expected that this medical device maker would post earnings of $0.26 per share when it actually produced earnings of $0.25, delivering a surprise of -3.85%. This quarterly report represents an earnings surprise of 8%. These figures are adjusted for non-recurring items. This compares to earnings of $0.27 per share a year ago. ![]() ![]() LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.25 per share. ![]()
0 Comments
Leave a Reply. |